11:12 AM EDT, 09/05/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were little changed late Friday morning with the S&P Europe Select ADR Index rising less than 0.1% to 1,520.44.

From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and semiconductor company Sequans Communications ( SQNS ) , which advanced 10% and 7% respectively. They were followed by biopharmaceutical company Genfit ( GNFT ) and biotech company Evaxion ( EVAX ) , which climbed 5.7% and 4.5% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and pharmaceutical company Novo Nordisk ( NVO ) , which dropped 4.5% and 2.1% respectively. They were followed by oil and gas company Eni (E) and petroleum refiner Equinor ( EQNR ) , which lost 1.9% and 1.5% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) and software firm Endava ( DAVA ) , which rose 3.1% and 2.2% respectively. They were followed by hospitality company InterContinental Hotels Group ( IHG ) and utilities company National Grid ( NGG ) , which were up 1.6% and 1.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and financial services company Barclays ( BCS ) , which fell 5.7% and 2% respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and oil and gas company BP (BP), which were down 1.7% each.